san

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

July 02, 2025 03:00 ET  | Source: Belite Bio, Inc -  500 subjects enrolled across the United States, the United…

2 months ago

AN Venture Partners Announces Final Close of $200M Fund I

One of the largest Japan focused biotech funds to dateSAN FRANCISCO & TOKYO--(BUSINESS WIRE)--AN Venture Partners (ANV), a global biotech…

2 months ago

Ameresco Receives Frost & Sullivan’s 2025 Global Company of the Year Award for Excellence in Energy Services

Recognized for customer-centric innovation, strategic execution, and leadership in flexible, turnkey energy solutions worldwide SAN ANTONIO, July 1, 2025 /PRNewswire/…

2 months ago

Siemens Receives Frost & Sullivan’s 2025 Europe, Middle East, and Africa Company of the Year Award for Excellence in Smart Water Meter Data Management

Siemens sets the benchmark in innovation and customer impact, helping utilities digitalize their operations and improve sustainable water management across EMEA…

2 months ago

The Ensign Group, Inc. Announces Retirement of Its Executive Chairman

June 20, 2025 16:30 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., June 20, 2025 (GLOBE NEWSWIRE)…

3 months ago

Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of Its Investigational Oral Obesity Candidates at the ADA 85th Scientific Sessions

Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…

3 months ago

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

June 20, 2025 19:30 ET  | Source: Structure Therapeutics Inc. SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics…

3 months ago

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share

June 19, 2025 16:05 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., June 19, 2025 (GLOBE NEWSWIRE)…

3 months ago

Stop Wasting AI on Personal Productivity: 60% of Leaders Pivot to Agentic Automation for Real Enterprise Value

New Research Confirms Costly Copilot Limitations, Driving Demand for Governed, Process-Centric AI Solutions That Accelerate Autonomy SAN JOSE, Calif., June…

3 months ago

RCKT INVESTOR NOTICE: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals,…

3 months ago